Shafer, A., Rubatt, J. M., Ayeni, T., Deal, A. M., Secord, A. A., Soper, J. T., … Gehring, P. A. (2008). Surgical cytoreduction and dose intensity of adjuvant paclitaxel and carboplatin chemotherapy in advanced epithelial ovarian cancer. In GYNECOLOGIC ONCOLOGY (Vol. 108, pp. S55–S56). ACADEMIC PRESS INC ELSEVIER SCIENCE.

Shafer, A., J. M. Rubatt, T. Ayeni, A. M. Deal, A. A. Secord, J. T. Soper, L. J. Havrilesky, L. Van Le, and P. A. Gehring. “Surgical cytoreduction and dose intensity of adjuvant paclitaxel and carboplatin chemotherapy in advanced epithelial ovarian cancer.” In GYNECOLOGIC ONCOLOGY, 108:S55–56. ACADEMIC PRESS INC ELSEVIER SCIENCE, 2008.

Shafer A, Rubatt JM, Ayeni T, Deal AM, Secord AA, Soper JT, et al. Surgical cytoreduction and dose intensity of adjuvant paclitaxel and carboplatin chemotherapy in advanced epithelial ovarian cancer. In: GYNECOLOGIC ONCOLOGY. ACADEMIC PRESS INC ELSEVIER SCIENCE; 2008. p. S55–6.

Shafer, A., et al. “Surgical cytoreduction and dose intensity of adjuvant paclitaxel and carboplatin chemotherapy in advanced epithelial ovarian cancer.” GYNECOLOGIC ONCOLOGY, vol. 108, no. 3, ACADEMIC PRESS INC ELSEVIER SCIENCE, 2008, pp. S55–56.

Shafer A, Rubatt JM, Ayeni T, Deal AM, Secord AA, Soper JT, Havrilesky LJ, Van Le L, Gehring PA. Surgical cytoreduction and dose intensity of adjuvant paclitaxel and carboplatin chemotherapy in advanced epithelial ovarian cancer. GYNECOLOGIC ONCOLOGY. ACADEMIC PRESS INC ELSEVIER SCIENCE; 2008. p. S55–S56.